Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature.

Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Abstract Text:

M Conti,A Salis,C Urigo,L Canalis,S Frau,G C Canalis,M Conti,A Salis,C Urigo,L Canalis,S Frau,G C Canalis,

PURPOSE: This article discusses the possible pathophysiological conditions responsible for magnetic resonance imaging (MRI) finding of transient focal lesions in the splenium of the corpus callosum on the basis of our experience and a review of the literature. MATERIALS AND METHODS: In six patients undergoing computed tomography (CT) and MRI examinations, focal nonhemorrhagic lesions of the splenium of the corpus callosum were incidentally discovered. Patients had been referred for suspected encephalitis (n=2), dural sinus thrombosis (n=1) and multiple sclerosis (n=3). MRI examinations were repeated after 4, 8 and 12 weeks and in two cases also after 6 and 9 months. MRI and medical records were retrospectively reviewed with respect to patients' clinical history, medication and laboratory findings to define lesion aetiology. RESULTS: In all patients, the lesions were isolated, reversible and with no contrast enhancement. In four patients, the lesion disappeared after complete remission of the underlying disease, whereas in two patients, they persisted for 6 and 9 months, respectively. CONCLUSIONS: To our knowledge and according to previous reports, the fact that these lesions are detected in a relatively large number of conditions with heterogeneous etiopathogenetic factors leads to the hypothesis that a common underlying pathophysiological mechanism that, considering signal characteristic, reversibility and white matter location, could be represented by vasogenic oedema.

Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Publishing Authors By Initials

M Conti,A Salis,C Urigo,L Canalis,S Frau,GC Canalis,M Conti,A Salis,C Urigo,L Canalis,S Frau,GC Canalis,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: La Radiologia medica

VOLUME: 112

Page Numbers: 921-35

Journal Abbreviation:

ISSN: 0033-8362

DAY: 20

MONTH: 09

YEAR: 2007

Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Information

Number of References:

LANGUAGE: ita

NlmUniqueID: 177625

Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature.

AFFILIATION: Istituto di Scienze Radiologiche dell'Università di Sassari, Viale S. Pietro 10, Sassari, Italy. mconti@uniss.it

Country: Italy

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Radiol Med (Torino)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature Related Publications

• Activation of the ERK pathway in osteoblastic cells, role of gremlin and BMP-2.
• Bone morphogenetic protein-2 suppresses collagenase-3 promoter activity in osteoblasts through a runt domain factor 2 binding site.
• Bone morphogenetic proteins induce gremlin, a protein that limits their activity in osteoblasts.
• CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia.
• CCAAT/enhancer binding protein homologous protein (DDIT3) induces osteoblastic cell differentiation.
• Conditional deletion of gremlin causes a transient increase in bone formation and bone mass.
• Connective tissue growth factor enhances osteoblastogenesis in vitro.
• Effect of growth factors on bone cell replication and differentiation.
• Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression.
• Expression and regulation of CCN genes in murine osteoblasts.
• Gene delivery by retroviruses.
• Growth hormone, insulin-like growth factors, and the skeleton.
• Local bone growth factors.
• Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia.
• Nephroblastoma overexpressed (nov) is a novel bone morphogenetic protein antagonist.
• Notch inhibits osteoblast differentiation and causes osteopenia.
• Notch signaling in osteoblasts.
• Regulation of collagenase-3 by bone morphogenetic protein-2 in bone cell cultures.
• Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia.
• Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts.
• Transient focal lesion in the splenium of the corpus callosum: MR imaging with an attempt to clinical-physiopathological explanation and review of the literature.
• Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.